| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/06/2006 | US7056701 Hormone and albumin fusion protein |
| 06/06/2006 | US7056698 Nucleic acids encoding interleukin-9 receptor variants |
| 06/06/2006 | US7056695 TNF-α variants |
| 06/06/2006 | US7056692 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta |
| 06/06/2006 | US7056689 Methods of treating and detecting cancer using viruses |
| 06/06/2006 | US7056681 For modulating cytokine, interferon, and tumor necrosis factor levels |
| 06/06/2006 | US7056677 Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them |
| 06/06/2006 | US7056662 Reducing the level of circulating free fatty acids by administering a compound that inhibits mal1, especially inhibiting transcription or translation of mal1 |
| 06/06/2006 | US7056530 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities |
| 06/06/2006 | US7056529 Vesicle comprises ATP and phospholipid; fusion proteins |
| 06/06/2006 | US7056523 Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine |
| 06/06/2006 | US7056517 Glucosyltransferase immunogens |
| 06/06/2006 | US7056516 Comprises nucleotide sequences coding caspase 8 inhibitory protein for use in the treatment of alzheimer's, parkinson's, arthritic, septic, cardiovascular, inflammatory, osteoporotic and ischemic reperfusion injuries/disorders |
| 06/06/2006 | US7056515 Antigens for immunocontraception |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056513 Peptides for use in the treatment of cancer and aging |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/06/2006 | US7056511 contacting said cells with a free light chain of immunoglobulin-binding peptide having a specific amino sequence; may be used to treat asthma, allergy, including contact allergy and occupational allergy, chronic inflammatory bowel disorders, viral infection, multiple sclerosis. and migraines |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056506 Methods for detecting and inhibiting angiogenesis |
| 06/06/2006 | US7056505 Antibody for use in the diagnosis, prevention and treatment of infections, autoimmune disorders, arthritis, graft rejection and graft-versus-host disease |
| 06/06/2006 | US7056504 Rationally designed heparinases derived from heparinase I and II |
| 06/06/2006 | US7056503 Antigrowth agents; solid support releasing protein |
| 06/06/2006 | US7056501 used to develop diagnostic assays for the detection of Neospora infections in cattle and other animals |
| 06/06/2006 | US7056499 For suppressing the growth of the body hair, thereby decreasing the removing frequency of the body hair |
| 06/06/2006 | US7056493 Radio-opaque polymer biomaterials |
| 06/06/2006 | CA2367105C A thrombin blood fraction for use in a medical procedure |
| 06/06/2006 | CA2367024C A thrombin blood fraction for use in a medical procedure |
| 06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 06/06/2006 | CA2120153C Recombinant immunotoxins |
| 06/06/2006 | CA2071214C Method of delivering molecules into eukaryotic cells |
| 06/06/2006 | CA2053288C Expression of human apolipoproteins ai and ai-milano in yeast |
| 06/06/2006 | CA1341506C Factor viii coagulant polypeptides and monoclonal antibodies to them |
| 06/01/2006 | WO2006058215A2 In situ method for treatment and repair of meniscal injuries |
| 06/01/2006 | WO2006058077A1 Dap-10 and uses thereof |
| 06/01/2006 | WO2006058024A2 Cellular receptors used in the treatment of inflammatory disease |
| 06/01/2006 | WO2006057997A2 Plasmin-inhibitory therapies |
| 06/01/2006 | WO2006057629A1 Agent for prophylaxis and treatment of a human reproductive system disorders filomek and method for the production thereof |
| 06/01/2006 | WO2006057389A1 Novel transcriptional factor phosphorylated by amp protein kinase and gene thereof |
| 06/01/2006 | WO2006057303A1 Glycopeptide antibiotic monomer derivatives |
| 06/01/2006 | WO2006057289A1 Novel shuttle vector |
| 06/01/2006 | WO2006057288A1 Glycopeptide antibiotic dimer derivatives |
| 06/01/2006 | WO2006057278A1 Remedy for heart disease using map kinase tnni3k |
| 06/01/2006 | WO2006056987A2 Leptin antagonists |
| 06/01/2006 | WO2006056885A2 Igf-1 isoforms |
| 06/01/2006 | WO2006056823A1 Modulating retinal pigmented epithelium permeation by inhibiting or activating vegfr-1 |
| 06/01/2006 | WO2006056733A1 Gamma-delta t cell receptors |
| 06/01/2006 | WO2006056492A1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis |
| 06/01/2006 | WO2006056479A1 Sly1 inhibitors in transplantation |
| 06/01/2006 | WO2006056370A1 Fusion protein comprising a bh3-domain of a bh3-only protein |
| 06/01/2006 | WO2006056259A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | WO2006056097A1 A pharmaceutical composition for treating senile dementia |
| 06/01/2006 | WO2006056027A1 Human cytomegalovirus immunotherapy |
| 06/01/2006 | WO2006056013A1 Stabilized calcium phosphate complexes |
| 06/01/2006 | WO2006039163A3 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 06/01/2006 | WO2006029487A3 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 06/01/2006 | WO2006020720A3 Stable pegylated interferon formulation |
| 06/01/2006 | WO2006020208A3 Therapeutic composition whit a botulinum neurotoxin |
| 06/01/2006 | WO2006014493A3 Mechanically activated channel blocker |
| 06/01/2006 | WO2006014468A3 Saif, an anti-inflammatory factor, and methods of use thereof |
| 06/01/2006 | WO2006010050A3 Modulation of synaptogenesis |
| 06/01/2006 | WO2005123958A3 Cd7 as biomarker and therapeutic target for psoriasis |
| 06/01/2006 | WO2005121801A3 Diagnosis of anemia and optimizing treatment for organ repair |
| 06/01/2006 | WO2005117939A3 Use of GPCR54 ligands for the treatment of infertility |
| 06/01/2006 | WO2005114203A3 Dominant b cell epitopes and methods of making and using thereof |
| 06/01/2006 | WO2005113595A3 High affinity ny-eso t cell receptor |
| 06/01/2006 | WO2005112968A3 Method of using recombinant human antithrombin for neurocognitive disorders |
| 06/01/2006 | WO2005112931A3 Methods related to the treatment of neurodegenerative and inflammatory conditions |
| 06/01/2006 | WO2005110014A3 Methods and compositions for using tsh in the inhibition of tnf activity |
| 06/01/2006 | WO2005097164A3 Use of cyclosporins for treatment of cerebral ischemia and brain and spinal cord injury |
| 06/01/2006 | WO2005048936A3 Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof |
| 06/01/2006 | WO2005047478A3 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 06/01/2006 | WO2005046516A3 Medical implants and anti-scarring agents |
| 06/01/2006 | WO2005034858A8 Compositions and methods for treatment of muscle pain and muscle wasting |
| 06/01/2006 | WO2005023190A3 Treatment for cd5+ b cell lymphoma |
| 06/01/2006 | WO2004091550A3 Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives |
| 06/01/2006 | WO2004085617B1 TIMP3 as VEGF inhibitor |
| 06/01/2006 | WO2004066932A3 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 06/01/2006 | WO2004004656A3 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 06/01/2006 | WO2003090675A3 Methods and compositions useful for treating prostate cancer |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060117414 Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof |
| 06/01/2006 | US20060116627 Compositions, kits, methods, and apparatus for transvascular delivery of a composition to an extravascular tissue of a mammal |
| 06/01/2006 | US20060116508 Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor |
| 06/01/2006 | US20060116507 Osteogenic devices |
| 06/01/2006 | US20060116505 Glucose and/or fructose transporter naglt1 and its gene |
| 06/01/2006 | US20060116344 Remedy and preventive for diseases caused by NF-kB |
| 06/01/2006 | US20060116341 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 06/01/2006 | US20060116339 Antisense modulation of purinoreceptor p2x3 |
| 06/01/2006 | US20060116328 Combined use of carnosinase inhibitor with l-carnosines and composition |
| 06/01/2006 | US20060116327 Antimicrobial compounds |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | US20060116325 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 06/01/2006 | US20060116324 Novel formulations |
| 06/01/2006 | US20060116323 Tumor-inhibiting protein and the use thereof |
| 06/01/2006 | US20060116322 Formation of novel erythropoietin conjugates using transglutaminase |
| 06/01/2006 | US20060116321 Immunosuppressive exosomes |
| 06/01/2006 | US20060116320 Growth hormone crystals and a process for production of these GH-crystals |
| 06/01/2006 | US20060116319 Method for identifying and treating photodamaged skin |
| 06/01/2006 | US20060116318 Preptin methods of use |